Calcitonin
Research News and Information

Monday, November 23, 2009

Heparin-binding protein: an early marker of circulatory failure in sepsis.

29 Sep 2009 BACKGROUND: The early detection of circulatory failure in patients with sepsis is important for successful treatment. Heparin-binding protein (HBP), released from activated neutrophils, is a potent inducer of vascular leakage. In this study, we ... Read more...

Calcitonin directly increases adrenocorticotropic hormone-stimulated corticosterone production in the hen adrenal gland.

29 Sep 2009 The present study was performed to elucidate whether the receptor for calcitonin (CT) exists in the adrenocortical cells of hens and to determine the effect of CT on adrenocorticotropic hormone (ACTH)-stimulated corticosterone production in its ... Read more...

Lessons from thymic epithelial heterogeneity: FoxN1 and tissue-restricted gene expression by extrathymic, endodermally derived epithelium.

26 Sep 2009 Modeling of thymic epithelial differentiation has been guided by several important underlying assumptions. One is that within epithelial tissues derived from pharyngeal endoderm, FoxN1 expression is signature for the thymic epithelial lineage. ... Read more...

Latest indexed articles for 'Calcitonin'

These are the very latest articles for this heading:

• Heparin-binding protein: an early marker of circulatory failure in sepsis. 29 Sep 2009
• Calcitonin directly increases adrenocorticotropic hormone-stimulated corticosterone production in the hen adrenal gland. 29 Sep 2009
• Lessons from thymic epithelial heterogeneity: FoxN1 and tissue-restricted gene expression by extrathymic, endodermally derived epithelium. 26 Sep 2009
• Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study. 19 Sep 2009
• Measurement of serum procalcitonin: a step closer to tailored care for respiratory infections? 7 Sep 2009
• Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. 7 Sep 2009
• Cell-free DNA as a noninvasive acute rejection marker in renal transplantation. Sep 2009
• [Incretin and bone] 30 Aug 2009
• Medullary thyroid carcinoma with poor differentiation and atypical radiographic pattern of metastasis. 30 Aug 2009
• Procalcitonin and C-reactive protein serum levels as markers of infection in a pediatric population with febrile neutropenia and cancer. 30 Aug 2009
• The status of serum procalcitonin in pulmonary tuberculosis and nontuberculosis pulmonary disease. 30 Aug 2009
• Procalcitonin as a biomarker for severe Plasmodium falciparum disease: a critical appraisal of a semi-quantitative point-of-care test in a cohort of travellers with imported malaria. 30 Aug 2009
• The usefulness of the semiquantitative procalcitonin test kit as a guideline for starting antibiotic administration. 30 Aug 2009
• The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy. 25 Aug 2009
• Construction of a recombinant eukaryotic expression plasmid containing human calcitonin gene and its expression in NIH3T3 cells. 17 Aug 2009
• Cinacalcet for hyperparathyroidism in pregnancy and puerperium. 30 Jul 2009
• Calcitonin in a protochordate, Ciona intestinalis--the prototype of the vertebrate calcitonin/calcitonin gene-related peptide superfamily. 30 Jul 2009
• Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels. 30 Jul 2009
• Prospective comparison of eubacterial PCR and measurement of procalcitonin levels with blood culture for diagnosing septicemia in intensive care unit patients. 27 Jul 2009
• Plasma procalcitonin is an independent predictor of graft failure late after renal transplantation. 25 Jul 2009

See a longer list of these articles.

Technical information about 'Calcitonin'

Definition: A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults.

Chemical name: Calcitonin

Registry Number: 9007-12-9

Descriptor UI: D002116

Alternative terms: Calcitonin; Calcitrin; Thyrocalcitonin; Calcitonin(1-32); Eel Calcitonin; Calcitonin, Eel; Ciba 47175-BA; Ciba 47175 BA; Ciba 47175BA;

Related Mesh Headings: Receptors, Calcitonin;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Bone Density Conservation Agents;

Tree Number: D06.472.699.150; D12.644.400.095; D12.644.548.150; D12.776.641.650.095;

Online Note: use CALCITONIN to search THYROCALCITONIN 1966-73

History Note: 74,66-67; was THYROCALCITONIN 1968-73 & 1964-65 (Prov 1964-65)